Skip to content

Ondansetron

Generic Medicine With 102 Brands Available In Bangladesh. Read What It Is For And How It Is Taken, Then Compare The Brands By Strength, Maker And Price.

Generic Guide

About Ondansetron

What This Generic Is For, How It Is Taken, And What To Watch For.

Indications

Post-operative nausea and vomiting Ondansetron is a serotonin subtype 3 (5-HT3) receptor antagonist indicated: Prevention of nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy. Prevention and treatment of post-operative nausea and vomiting. Prevention of radiotherapy-induced nausea and vomiting.

Dosage And Administration

Chemotherapy-Induced Nausea and Vomiting-Adults, Pediatric patients (6 months to 18 years): 8 mg tablet/orodispersible tablet: Three 0.15 mg/kg doses, up to a maximum of 16 mg per dose. 4 mg orodispersible tablet: Three 0.15 mg/kg doses, up to a maximum of 16 mg per dose. Injection: Three 0.15 mg/kg doses, up to a maximum of 16 mg per dose, infused intravenously over 15 minutes. Radiotherapy-Induced Nausea and Vomiting-Adults: 8 mg tablet/orodispersible tablet: Initial Dose: 8 mg orally 1 to 2 hours before radiotherapy. Post Radiotherapy: 8 mg orally every 8 hours for up to 5 days after a course of treatment. 4 mg orodispersible tablet: Three 0.15 mg/kg doses, up to a maximum of 16 mg per dose. Injection: Three 0.15 mg/kg doses, up to a maximum of 16 mg per dose, infused intravenously over 15 minutes. Postoperative Nausea and Vomiting-Adults: 8 mg tablet/orodispersible tablet: 16 mg given as two 8 mg tablets 4 mg orodispersible tablet: 16 mg Injection: 4 mg Pediatrics (>40 kg): Injection: 4 mgPediatrics (40 kg): Injection: 0.1 mg/kgChemotherapy-induced Nausea and Vomiting-Adults/Geriatric/Child of 12 years or over: Highly emetogenic cancer chemotherapy: 30 ml (24 mg) Ondansetron Oral Solution administered 30 minutes before start of emetogenic chemotherapy. Moderate emetogenic cancer chemotherapy: 10 ml (8 mg) Ondansetron Oral Solution administered 30 minutes before start of emetogenic chemotherapy. A further 10 ml dose should be administered after 8 hours of the first dose. One 10 ml dose should be administered twice a day (every 12 hours) for 1-2 days after completion of chemotherapy. Pediatric (4-11 years): 5 ml (4 mg) Ondansetron Oral Solution should be taken 30 minutes before the start of chemotherapy. The other 2 doses should be taken 4 and 8 hours after the first dose. Then 5 ml oral solution should be administered 3 times a day (every 8 hours) for 1-2 days after completion of chemotherapy. Oral solution: Radiotherapy induced Nausea and Vomiting (Adults/Geriatric/Child of 12 years or over): The recommended oral dosage: 10 ml (8 mg) Ondansetron Oral Solution 3 times daily. For total body irradiation: 10 ml (8-mg) Ondansetron Oral Solution should be administered 1 to 2 hours before each fraction of radiotherapy administered each day. For single high-dose fraction radiotherapy to the abdomen: one 10 ml Ondansetron Oral Solution should be administered 1 to 2 hours before radiotherapy, with subsequent doses every 8 hours after the first dose for 1 to 2 days after completion of radiotherapy. For daily fractionated radiotherapy to the abdomen: 10 ml (8-mg) Ondansetron Oral Solution should be administered 1 to 2 hours before radiotherapy, with subsequent doses every 8 hours after the first dose for each day radiotherapy is given. Postoperative Nausea and Vomiting (Adults/Geriatric/Child of 12 years or over): 20 ml (16 mg) Ondansetron Oral Solution 1 hour before induction of anesthesia Oral Soluble Film: Prevention of nausea and vomiting associated with highly emetogenic cancer chemotherapy: Adult oral dose: 24 mg given successively as three 8 mg films 30 minutes before the start of chemotherapy. Prevention of nausea and vomiting associated with moderately emetogenic cancer chemotherapy: Adults and pediatric patients 12 years of age and older: One 8 mg film 30 minutes before chemotherapy followed by an 8 mg dose 8 hours later. Administer one 8 mg film twice a day (every 12 hours) for 1 to 2 days after completion of chemotherapy. Pediatric patients 4 through 11 years of age: One 4 mg film three times a day. Administer the first dose 30 minutes before chemotherapy, with subsequent doses 4 and 8 hours later. Administer one 4 mg film three times a day (every 8 hours) for 1 to 2 days after completion of chemotherapy. Prevention of nausea and vomiting associated with radiotherapy: The adult dosage is one 8 mg film three times a day. Postoperative nausea and vomiting: The adult dose is 16 mg given successively as two 8 mg films 1 hour before anesthesia.

Side Effects

Frequently reported adverse events were headache, constipation and diarrhea, but the majority have been mild or moderate in nature. In chemotherapy-induced nausea and vomiting, rash has occurred in approximately 1% of patients receiving Ondansetron. There also have been reports to a sensation of flushing or warmth, hiccups and liver enzyme abnormalities. Rare cases of anaphylaxis, brochospasm, tachycardia, angina (chest pain), hypokalemia, shortness of breath have also been reported, except for bronchospasm and anaphylaxis, the relationship to Ondansetron is unclear. There have been no evidence to extrapyramidal reactions, in rare case oculogyric crisis appearing alone, as well as with other dystonic reactions without definitive clinical evidence. In case of PONV, with the exception of headache, rates of these events were not significantly different in the Ondansetron and placebo groups.

Precautions And Warnings

Hypersensitivity reactions have been reported in patients who have exhibited hypersensitivity to other selective 5-HT3 receptor antagonists. Ondansetron is not a drug that stimulates gastric or intestinal peristalsis. It should not be used instead of nasogastric suction. The use of Ondansetron in patients following abdominal surgery or in patients with chemotherapy-induced nausea and vomiting may mask a progressive ileus and/or gastric distension.

Pregnancy And Lactation

Carcinogenic effects were not seen in 2-year studies in rats and mice with oral Ondansetron doses up to 10 and 30 mg/kg per day, respectively. Ondansetron was not mutagenic in standard tests for mutagenicity. Oral administration of Ondansetron up to 15 mg/kg per day did not affect fertility or general reproduction performance of male and female rats.Reproduction studies have been performed in pregnant rats and rabbits at daily oral doses up to 15 and 30 mg/kg per day, respectively, and have revealed no evidence of impaired fertility or harm to the fetus due to Ondansetron. There are, however, no adequate and well-controlled studies in pregnant women. Ondansetron is excreted in the breast milk of rats. So caution should be exercised when Ondansetron is administered to a nursing women.

Advertisement

Google Ads 970 x 250
Google Ads 300 x 250

Clinical Details

BestinMeds shares medicine information to help you compare. It does not replace advice from your doctor or pharmacist.

Advertisement

Google Ads 970 x 250
Google Ads 300 x 250

Available Brand Names: 102

Sorted By
IM/IV Injection

Onsat 8 mg/4 ml

Generic: Ondansetron

25.00Taka / 4 ml ampoule

View Medicine
Tablet

Onsat 8 mg

Generic: Ondansetron

10.00Taka / Unit

View Medicine
Oral Soluble Film

Onsat OSF 4 mg

Generic: Ondansetron

12.00Taka / Unit

View Medicine
Oral Soluble Film

Onsat OSF 8 mg

Generic: Ondansetron

18.00Taka / Unit

View Medicine
Oral Solution

Onstar 4 mg/5 ml

Generic: Ondansetron

45.00Taka / 50 ml

View Medicine
Dispersible Tablet

Onstar ODT 8 mg

Generic: Ondansetron

10.00Taka / Unit

View Medicine
Tablet

Osedan 8 mg

Generic: Ondansetron

10.00Taka / Unit

View Medicine
IM/IV Injection

Osetron 8 mg/4 ml

Generic: Ondansetron

25.17Taka / 4 ml ampoule

View Medicine
Oral Solution

Osetron 4 mg/5 ml

Generic: Ondansetron

30.20Taka / 50 ml

View Medicine
Tablet

Osetron 8 mg

Generic: Ondansetron

10.07Taka / Unit

View Medicine
Tablet

Periset 8 mg

Generic: Ondansetron

10.03Taka / Unit

View Medicine
IM/IV Injection

Periset 8 mg/4 ml

Generic: Ondansetron

30.10Taka / 4 ml ampoule

View Medicine
Oral Solution

Periset 4 mg/5 ml

Generic: Ondansetron

45.00Taka / 50 ml

View Medicine
IM/IV Injection

Premesis 8 mg/4 ml

Generic: Ondansetron

25.00Taka / 4 ml ampoule

View Medicine
Oral Solution

Premesis 4 mg/5 ml

Generic: Ondansetron

40.00Taka / 50 ml

View Medicine
Tablet

Premesis 8 mg

Generic: Ondansetron

10.00Taka / Unit

View Medicine
Tablet

Premesis 4 mg

Generic: Ondansetron

4.50Taka / Unit

View Medicine
Tablet

Pukenil 8 mg

Generic: Ondansetron

9.00Taka / Unit

View Medicine
Oral Solution

Pukenil 4 mg/5 ml

Generic: Ondansetron

44.00Taka / 50 ml

View Medicine
IM/IV Injection

Seroset 8 mg/4 ml

Generic: Ondansetron

25.00Taka / 4 ml ampoule

View Medicine
Tablet

Seroset 8 mg

Generic: Ondansetron

7.00Taka / Unit

View Medicine
Tablet

Seton 8 mg

Generic: Ondansetron

5.00Taka / Unit

View Medicine
Tablet

Setronax 8 mg

Generic: Ondansetron

10.00Taka / Unit

View Medicine
Tablet

Vomidyl 8 mg

Generic: Ondansetron

10.00Taka / Unit

View Medicine

Advertisement

Google Ads 970 x 250
Google Ads 300 x 250